Rhenman & Partners Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-25,000
| Closed | -$41K | – | 117 |
|
|
2017
Q2 | $41K | Hold |
25,000
| – | – | 0.01% | 108 |
|
|
2017
Q1 | $85K | Hold |
25,000
| – | – | 0.01% | 104 |
|
|
2016
Q4 | $130K | Sell |
25,000
-12,500
| -33% | -$65K | 0.02% | 106 |
|
|
2016
Q3 | $945K | Hold |
37,500
| – | – | 0.15% | 89 |
|
|
2016
Q2 | $927K | Sell |
37,500
-16,875
| -31% | -$417K | 0.16% | 88 |
|
|
2016
Q1 | $1.58M | Buy |
54,375
+23,125
| +74% | +$670K | 0.31% | 80 |
|
|
2015
Q4 | $1.16M | Hold |
31,250
| – | – | 0.18% | 94 |
|
|
2015
Q3 | $1.52M | Sell |
31,250
-46,200
| -60% | -$2.25M | 0.24% | 85 |
|
|
2015
Q2 | $5.34M | Sell |
77,450
-10,214
| -12% | -$704K | 0.64% | 52 |
|
|
2015
Q1 | $3.14M | Buy |
87,664
+37,664
| +75% | +$1.35M | 0.53% | 64 |
|
|
2014
Q4 | $632K | Hold |
50,000
| – | – | 0.18% | 84 |
|
|
2014
Q3 | $768K | Buy |
50,000
+12,500
| +33% | +$192K | 0.22% | 91 |
|
|
2014
Q2 | $1.02M | Buy |
37,500
+22,760
| +154% | +$617K | 0.3% | 88 |
|
|
2014
Q1 | $395K | Sell |
14,740
-172
| -1% | -$4.61K | 0.12% | 90 |
|
|
2013
Q4 | $366K | Buy |
+14,912
| New | +$366K | 0.14% | 82 |
|